In Brief: Celgene Synovir
Executive Summary
Celgene Synovir: Thalidomide for erythema nodosum leprosum will be reviewed by FDA's Dermatologic and Ophthalmic Drugs Advisory Committee Sept. 4-5 at the Holiday Inn-Bethesda, Md. NDA (20-785) was submitted in December. The meeting will begin at 8:30 a.m. each day...
Celgene Synovir: Thalidomide for erythema nodosum leprosum will be reviewed by FDA's Dermatologic and Ophthalmic Drugs Advisory Committee Sept. 4-5 at the Holiday Inn-Bethesda, Md. NDA (20-785) was submitted in December. The meeting will begin at 8:30 a.m. each day.... |